|
PPFIA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.27820000040258E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8742899999924E-05 |
| Normal-vs-Stage2 |
9.239700E-04 |
| Normal-vs-Stage3 |
1.11950000047933E-07 |
| Normal-vs-Stage4 |
2.390400E-04 |
| Stage1-vs-Stage2 |
8.723000E-01 |
| Stage1-vs-Stage3 |
1.022830E-01 |
| Stage1-vs-Stage4 |
6.389000E-01 |
| Stage2-vs-Stage3 |
3.308600E-01 |
| Stage2-vs-Stage4 |
8.441400E-01 |
| Stage3-vs-Stage4 |
4.271400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.16270000031172E-07 |
| Normal-vs-AfricanAmerican |
1.212350E-04 |
| Normal-vs-Asian |
9.147400E-01 |
| Caucasian-vs-AfricanAmerican |
6.339000E-01 |
| Caucasian-vs-Asian |
1.018000E-01 |
| AfricanAmerican-vs-Asian |
8.695900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74135999999603E-05 |
| Normal-vs-Female |
1.00339999975496E-07 |
| Male-vs-Female |
6.060800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.793880E-04 |
| Normal-vs-Age(41-60Yrs) |
1.627430E-04 |
| Normal-vs-Age(61-80Yrs) |
8.32700000064079E-08 |
| Normal-vs-Age(81-100Yrs) |
2.414300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.155550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.771000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.300600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.330000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.575800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.501400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.513200E-01 |
| Normal-vs-Grade 2 |
1.168220E-04 |
| Normal-vs-Grade 3 |
7.45610000407737E-08 |
| Normal-vs-Grade 4 |
3.84239999999814E-05 |
| Grade 1-vs-Grade 2 |
1.130980E-01 |
| Grade 1-vs-Grade 3 |
8.051700E-02 |
| Grade 1-vs-Grade 4 |
2.622400E-02 |
| Grade 2-vs-Grade 3 |
1.543790E-01 |
| Grade 2-vs-Grade 4 |
1.791210E-01 |
| Grade 3-vs-Grade 4 |
6.922200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.409100E-04 |
| Normal-vs-ccB subtype |
2.24149999672463E-08 |
| ccA subtype-vs-ccB subtype |
3.018100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.38229999996553E-06 |
| Normal-vs-N1 |
1.061730E-02 |
| N0-vs-N1 |
9.270600E-01 |
|
|
